These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 23287055

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
    Seierstad M, Breitenbucher JG.
    J Med Chem; 2008 Dec 11; 51(23):7327-43. PubMed ID: 18983142
    [No Abstract] [Full Text] [Related]

  • 24. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
    Meyers MJ, Long SA, Pelc MJ, Wang JL, Bowen SJ, Walker MC, Schweitzer BA, Madsen HM, Tenbrink RE, McDonald J, Smith SE, Foltin S, Beidler D, Thorarensen A.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6538-44. PubMed ID: 21924614
    [Abstract] [Full Text] [Related]

  • 25. 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.
    Zahov S, Garzinsky D, Hanekamp W, Lehr M.
    Bioorg Med Chem; 2017 Feb 01; 25(3):825-837. PubMed ID: 27989417
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
    Käsnänen H, Myllymäki MJ, Minkkilä A, Kataja AO, Saario SM, Nevalainen T, Koskinen AM, Poso A.
    ChemMedChem; 2010 Feb 01; 5(2):213-31. PubMed ID: 20024981
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
    Sunduru N, Svensson M, Cipriano M, Marwaha S, Andersson CD, Svensson R, Fowler CJ, Elofsson M.
    J Enzyme Inhib Med Chem; 2017 Dec 01; 32(1):513-521. PubMed ID: 28114819
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.
    Tian G, Paschetto KA, Gharahdaghi F, Gordon E, Wilkins DE, Luo X, Scott CW.
    Biochemistry; 2011 Aug 16; 50(32):6867-78. PubMed ID: 21728345
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
    Zahov S, Drews A, Hess M, Schulze Elfringhoff A, Lehr M.
    ChemMedChem; 2011 Mar 07; 6(3):544-9. PubMed ID: 21259444
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
    Tarzia G, Duranti A, Gatti G, Piersanti G, Tontini A, Rivara S, Lodola A, Plazzi PV, Mor M, Kathuria S, Piomelli D.
    ChemMedChem; 2006 Jan 07; 1(1):130-9. PubMed ID: 16892344
    [Abstract] [Full Text] [Related]

  • 37. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: bioisosteric replacement of the carboxylic acid moiety.
    Althaus J, Hake T, Hanekamp W, Lehr M.
    J Enzyme Inhib Med Chem; 2016 Jan 07; 31(sup1):131-140. PubMed ID: 27162011
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
    Richter HG, Angehrn P, Hubschwerlen C, Kania M, Page MG, Specklin JL, Winkler FK.
    J Med Chem; 1996 Sep 13; 39(19):3712-22. PubMed ID: 8809160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.